MyFinsight
Home
About
Contact
ewtx: the income statement
Download
Download image
Total comprehensive
loss
-$40,169K
Unrealized gain on
available-for-sale securities
$497K
Interest income
$6,192K
Net loss
-$40,666K
Total other income
$6,192K
Loss from operations
-$46,858K
Total operating
expenses
$46,858K
General and
administrative
$9,378K
Research and development
$37,480K
Back
Back
Income Statement
source: myfinsight.com
Edgewise Therapeutics, Inc. (EWTX)
Edgewise Therapeutics, Inc. (EWTX)